|1.||Stehouwer, Jeffrey S: 1 article (01/2003)|
|2.||Gault, Ruth A: 1 article (01/2003)|
|3.||Hunter, Kenneth W: 1 article (01/2003)|
|4.||Tam-Chang, Suk-Wah: 1 article (01/2003)|
01/01/1999 - "The proposed arthro-preventive action of cetyl myristoleate, an OTC product sold as a nutritional supplement, could not be confirmed, using an almost identical bioassay (adjuvant-induced polyarthritis in rats) as that described in the original report (Diehl and May, 1994) with the same, and 3 other, dosing schedules."
01/01/2003 - "Cetyl myristoleate (CM) was reported by Diehl and May [J Pharm Sci 83 (1994) 296] to block inflammation and prevent adjuvant-induced arthritis in rats. "
03/01/1994 - "Cetyl myristoleate was isolated from National Institutes of Health, general purpose, Swiss albino mice that were immune to the polyarthritis induced in rats with Freund's adjuvant. "